Prospects for the treatment of B cell tumors using idiotypic vaccination (Q38246920)

1 September 2017

1 reference

title

Prospects for the treatment of B cell tumors using idiotypic vaccination (English)

1 reference

1 September 2017

2

Stevenson FK

1 reference

1 September 2017

George AJ

1

1 reference

1 September 2017

1 January 1989

1 reference

International Reviews of Immunology

1 September 2017

1 reference

1 September 2017

4

1 reference

1 September 2017

4

1 reference

1 September 2017

271-310

1 reference

Antibody to a molecularly-defined antigen confined to a tumour cell surface

1 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Suppression of hapten-specific delayed-type hypersensitivity responses in mice by idiotype-specific suppressor T cells after administration of anti-idiotypic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Mice whose B cells cannot produce the T15 idiotype also lack an antigen-specific helper T cell required for T15 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Suppression by autogenous complementary idiotypes: the priority of the first response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Immunoregulation of Murine Myeloma Cell Growth and Differentiation; A Monoclonal Model of B Cell Differentiation1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Myeloma proteins as tumor-specific transplantation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Suppression of MOPC-167 GrowthIn Vivoby Immunization against the Idiotype of the MOPC-167 Myeloma Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Cell-Bound Myeloma Proteins on the Surface of Myeloma Cells: Potential Targets for the Immune System

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Spontaneous murine B-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Neoplastic B cells as targets for antibody-ricin A chain immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Characterisation of a new murine B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Mouse x human heterohybridomas as fusion partners with human B cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Immunotherapy of Cancer: An Experimental Model in Syngeneic Guinea Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Tumour prevention and rejection with recombinant vaccinia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Immunologically-mediated restraint of latent tumour metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

The physiology of B cells as studied with tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Unique tumor-specific antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Evasion of host defences by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Mechanisms by which Activated Macrophages Inhibit Lymphocyte Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Immunoglobulin heavy chain toxicity in plasma cells is neutralized by fusion to pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Heavy Chain Diseases: Current Findings and Concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Idiotype variant cell populations in patients with B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

An antiserum which recognizes lipopolysaccharidereactive B cells in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Mutations affecting immunoglobulin light chain secretion by myeloma cells I. Functional analysis by cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Secretion of a lambda 2 immunoglobulin chain is prevented by a single amino acid substitution in its variable region.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Immunocompetence and malignant lymphoma: immunologic status before therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Cellular and Humoral Immunity in Non-Hodgkin’s Lymphoma: Correlation of Immunodeficiencies with Clinicopathologic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Current status of immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Can cancer chemotherapy enhance the malignant behaviour of tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Anti-idiotypic antibodies and the induction of specific tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Tumour-dormant states established with L5178Y lymphoma cells in immunised syngeneic murine hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

Univalent antibodies kill tumour cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044783

10.3109/08830188909044783

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

2519930